- Investigator
- Renee F Modica
- Status
- Accepting Candidates
Research at a glance
Top areas of exploration
- Lupus Erythematosus, Systemic , 3 publications
- Rituximab , 3 publications
- Immunosuppressive Agents , 3 publications
- Rheumatic Diseases , 2 publications
Research activity
Active clinical trials
- Investigator
- Renee F Modica
- Status
- Accepting Candidates
My publications
Filter publications
24 publications
2025
Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study.
Arthritis & rheumatology (Hoboken, N.J.)
鈥�2023
Bortezomib is efficacious in the treatment of severe childhood-onset neuropsychiatric systemic lupus erythematosus with psychosis: a case series and mini-review of B-cell immunomodulation in antibody-mediated diseases
Clinical Rheumatology
2023
Case Report: Refractory macrophage activation syndrome requiring high-dose anakinra, emapalumab, and etoposide therapy in early-onset systemic juvenile idiopathic arthritis associated with adenoviremia.
Frontiers in pediatrics
鈥�2023
Does kidney biopsy in pediatric lupus patients "complement" the management and outcomes of silent lupus nephritis? Lessons learned from a pediatric cohort.
Pediatric nephrology (Berlin, Germany)
鈥�2021
The Diagnostic Performance of Early Sj枚gren's Syndrome Autoantibodies in Juvenile Sj枚gren's Syndrome: The University of Florida Pediatric Cohort Study.
Frontiers in immunology
鈥�